Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 12 Non-Muscle Invasive Bladder Neoplasms 4 Carcinoma, Transitional Cell 2 Ureteral Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Kidney Neoplasms 1 Hematuria 1 Carcinoma in Situ 1

Interventions

pembrolizumab 90 Blood Specimen Collection 41 Cyclophosphamide 37 Bevacizumab 36 Nivolumab 35 Standard of Care 32 Carboplatin 31 Surveys and Questionnaires 29 Paclitaxel 27 atezolizumab 25 Exercise 25 Pemetrexed 24 Gemcitabine 24 Cisplatin 23 Fluorouracil 22 Radiotherapy 20 Leucovorin 20 Dexamethasone 20 Docetaxel 19 Oxaliplatin 18 Rituximab 16 Irinotecan 16 Cetuximab 16 dostarlimab 15 Drug Therapy 15 Doxorubicin 15 Ipilimumab 14 Biopsy 14 130-nm albumin-bound paclitaxel 14 fludarabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Cystoscopy × 1 year × Clear all

NCT05796375 2026-05-04

ReplaceCysto

White River Junction Veterans Affairs Medical Center

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡